JAMA+ Women's Health

JAMA+ Women’s Health is a curated source of trusted clinical information from the JAMA Network that advances health care for women worldwide.

[JAMA+ Women's Health @JAMAWomenHealth]

Explore these curated insights and research in JAMA+ Women’s Health.

📬 Sign up for the JAMA+ Women's Health email newsletter: https://t.co/2s8I1og2OP

[JAMA+ Women's Health @JAMAWomenHealth]

In JAMA+ Women’s Health, we highlight new clinical and translational science:

1️⃣ A Perspective in JAMA, details how women often show clinical resilience despite greater Alzheimer disease pathology, raising important questions for diagnosis and care.

🔗 https://t.co/OtkR9xB7kI

[JAMA+ Women's Health @JAMAWomenHealth]

2️⃣ Additionally, an Original Investigation in JAMA Oncology presents phase 1/2 results for avelumab plus methotrexate as first-line therapy in low-risk gestational trophoblastic tumors, informing treatment advances in rare #reproductive cancers.

🔗 https://t.co/GeDUKDIcPU

[JAMA+ Women's Health @JAMAWomenHealth]

Explore this and more research on the intersection of #reproductive #health and health policy in JAMA+ Women’s Health.

📬 Sign up for the JAMA+ Women's Health email newsletter: https://t.co/oj3pw8Hmpw

[JAMA+ Women's Health @JAMAWomenHealth]

JAMA+ Women’s Health spotlights an Original Investigation in JAMA assessing the impact of state abortion bans after Dobbs v Jackson on management of spontaneous abortion among commercially insured individuals in the United States.

https://t.co/KfZCjyGURH

[JAMA+ Women's Health @JAMAWomenHealth]

Discover the latest expert commentary and guidance in JAMA+ Women’s Health.

📬 Sign up for the JAMA+ Women's Health email newsletter: https://t.co/dJF9RVOyxv

[JAMA+ Women's Health @JAMAWomenHealth]

This edition of JAMA+ Women’s Health features a Viewpoint in JAMA that revisits ongoing debates around osteoporotic fracture prevention, including the roles and risks of estrogen therapy and the implications of relying on abbreviated drug trials.

https://t.co/tNzA05nFhN

[JAMA+ Women's Health @JAMAWomenHealth]

Pregnant individuals with the highest #SedentaryBehavior (≥10 hours/day) had twice the risk of adverse pregnancy outcomes compared with those spending less time sitting.

https://t.co/1pLvf4admz

[JAMA+ Women's Health @JAMAWomenHealth]

Universal, first-dollar contraception coverage in British Columbia reduced out-of-pocket costs by 83% over two years, with the largest cost reductions among individuals aged 20 to 29 years.

https://t.co/yPPjaEqrYb

[JAMA+ Women's Health @JAMAWomenHealth]

Avelumab combined with methotrexate resulted in >95% durable remission and preserved #fertility in low-risk gestational trophoblastic #tumors, with a manageable safety profile.

https://t.co/TSAziqzX9Y

[JAMA+ Women's Health @JAMAWomenHealth]

💬 Perspective: Women with #AlzheimerDisease display greater tau pathology but outperform men in memory and function until a later, more rapid decline, suggesting female-specific clinical resilience to neuropathologic burden.

https://t.co/jHyOOvyCNq

[JAMA+ Women's Health @JAMAWomenHealth]

After Dobbs v Jackson, states with abortion bans saw more expectant management and less medication management for miscarriage, with persistent reliance on misoprostol-only regimens.

https://t.co/eWzO9saVJW

[JAMA+ Women's Health @JAMAWomenHealth]

💬 Viewpoint: Recent regulatory changes allow osteoporosis drugs to be approved based on bone density rather than fractures, but long-term benefit and safety remain uncertain; improved patient education and prevention earlier in life are essential.

https://t.co/7LztxZt7fv

[JAMA+ Women's Health @JAMAWomenHealth]

In a single-center cohort, 31 live births were achieved after uterus transplant, with high maternal and neonatal complication rates but no graft loss or severe morbidity.

https://t.co/OB0s5KQEjH

[JAMA+ Women's Health @JAMAWomenHealth]

💬 Perspective: A National Academies report identifies missed opportunities to prevent pregnancy-related #CardiovascularDisease, highlighting gaps in risk identification and care continuity before, during, and after pregnancy.

https://t.co/C2FMuukeg1

[JAMA+ Women's Health @JAMAWomenHealth]

#Prepregnancy care and counseling encompass a range of interventions to improve #maternal and #neonatal outcomes.

📌 This JAMA Review summarizes the current evidence for prepregnancy care and counseling with a primary care focus.

https://t.co/Lfj8ji2qZ7

[JAMA+ Women's Health @JAMAWomenHealth]

This population-based study found that Ontario physicians increased their workload during early pregnancy, with a reduction in clinical activity in the third trimester and pronounced specialty differences in leave duration and return-to-work patterns.

https://t.co/1EFuJbe4XH

[JAMA+ Women's Health @JAMAWomenHealth]

In a single-center cohort, 31 live births were achieved after uterus transplant, with high maternal and neonatal complication rates but no graft loss or severe morbidity.

https://t.co/yTAC0JcLaV

[JAMA+ Women's Health @JAMAWomenHealth]

💬 Perspective: A National Academies report identifies missed opportunities to prevent pregnancy-related #CardiovascularDisease, highlighting gaps in risk identification and care continuity before, during, and after pregnancy.

https://t.co/XTs3g6ofFo

[JAMA+ Women's Health @JAMAWomenHealth]

Prenatal structured #PEFLOW reduced postpartum #SUI incidence at 6 weeks (8.7% vs 13.9%) in primiparous women and improved pelvic floor strength, with sustained benefit through 12 months.

https://t.co/t8iFGOu3Lk